<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02945475</url>
  </required_header>
  <id_info>
    <org_study_id>HS-09-00395</org_study_id>
    <nct_id>NCT02945475</nct_id>
  </id_info>
  <brief_title>Neural Mechanisms for Appetitive Responses to High Reward Foods</brief_title>
  <official_title>Neural Mechanisms for Appetitive Responses to High Reward Foods</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Southern California</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Southern California</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is aimed at understanding neuroendocrine responses to different types of sugars&#xD;
      and how this influences feeding behavior among lean, overweight, and obese individuals.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators have previously combined functional magnetic resonance imaging (fMRI) with&#xD;
      hormonal and behavioral assessments to better understand the impacts of glucose and fructose&#xD;
      on appetite and its central regulation in humans and have made important observations in lean&#xD;
      individuals linking fructose consumption to overeating and obesity. The investigators now&#xD;
      propose to expand this work by examining the impacts of glucose and fructose ingested&#xD;
      together (sucrose), as occurs in real life, and by examining effects of a common&#xD;
      non-nutritive sweetener, sucralose, on brain and appetitive response. The investigators&#xD;
      propose a random-order crossover design to determine the effects of caloric and non-nutritive&#xD;
      sweeteners among lean, overweight, and obese participants. The investigators will measure&#xD;
      circulating levels of hormones involved in satiety signaling, quantify food intake, and&#xD;
      measure brain activity using blood-oxygen level dependent and arterial spin labeling methods&#xD;
      and functional connectivity analyses.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2016</start_date>
  <completion_date type="Actual">March 13, 2020</completion_date>
  <primary_completion_date type="Actual">March 13, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Changes of Blood oxygen level-dependent (BOLD) signal responses to food vs non-food cues after ingestion of different types of sugar. BOLD signal responses to food cues will be compared at the level of whole brain and within a priori regions of interest.</measure>
    <time_frame>Sessions 1, 2, 3, 4</time_frame>
    <description>These will be compared between ingestion of drinks and at level of whole brain and in regions of interest</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cerebral Blood Flow Response</measure>
    <time_frame>Sessions 1, 2, 3, 4</time_frame>
    <description>Arterial spin labeling with be used to determine brain areas with relative increases or decreases in CBF after ingestion of sucrose, glucose, or sucralose.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Systemic Metabolite and Hormone Responses</measure>
    <time_frame>Sessions 1, 2, 3, 4</time_frame>
    <description>The effects of sugar ingestion on changes in systemic metabolite (glucose) and hormone (insulin, GLP-1, leptin, ghrelin, peptide YY) levels will be assessed.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Functional Connectivity between regions involved in regulation of food intake</measure>
    <time_frame>Sessions 1, 2, 3, 4</time_frame>
    <description>Investigators will perform a physiological-psychological-interaction (PPI) analysis using the nucleus accumbens as the seed to explore brain regions showing increased functional connectivity to the seed during the food-cue task.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Appetite Ratings</measure>
    <time_frame>Sessions 1, 2, 3, 4</time_frame>
    <description>Ratings of hunger and desire for food in response to food vs non-food cues will be analyzed using a repeated-measures ANOVA with condition (glucose, sucrose, sucralose) and stimulus (food vs non-food) as within-subject factors.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ad Libitum Food Intake</measure>
    <time_frame>Sessions 1, 2, 3, 4</time_frame>
    <description>Total calories consumed and percent calories from sugar, fat and protein will be compared between conditions.</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">114</enrollment>
  <condition>Appetitive Behavior</condition>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>obese</arm_group_label>
    <description>Individuals ages 18 to 35 years of age with body mass index (BMI) 30-40 kg/m2</description>
  </arm_group>
  <arm_group>
    <arm_group_label>lean</arm_group_label>
    <description>Individuals ages 18 to 35 years of age with BMI of 19-24.9 kg/m2</description>
  </arm_group>
  <arm_group>
    <arm_group_label>overweight</arm_group_label>
    <description>Individuals ages 18 to 35 years of age with BMI of 25-29.9 kg/m2</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood Samples&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Participants in the greater Los Angeles area will be recruited. Lean, overweight, and obese&#xD;
        participants will be recruited.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age 18-35 years, right-handed, weight change &lt;2% for at least 3 months prior to&#xD;
             participation, no history of diabetes or other significant medical problems, fasting&#xD;
             glucose &lt;126 mg/dl.&#xD;
&#xD;
          -  Lean group: BMI of 19-24.9 kg/m2&#xD;
&#xD;
          -  Obese Group: BMI 30-40 kg/m2&#xD;
&#xD;
          -  Overweight Group: BMI of 25-29.9 kg/m2&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Neurological, psychiatric or addiction disorder, fasting glucose â‰¥126 mg/dl, use of&#xD;
             prescription medication (with the exception of contraceptives), tobacco use,&#xD;
             contraindications to MRI scanning (detailed in Protection of Human Subjects), fructose&#xD;
             intolerance, history of eating disorder, actively trying to lose weight.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kathleen Page, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Southern California</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Alexandra Yunker</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90089</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>June 28, 2016</study_first_submitted>
  <study_first_submitted_qc>October 24, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 26, 2016</study_first_posted>
  <last_update_submitted>April 17, 2021</last_update_submitted>
  <last_update_submitted_qc>April 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Southern California</investigator_affiliation>
    <investigator_full_name>Kathleen Page</investigator_full_name>
    <investigator_title>Associate Professor of Medicine</investigator_title>
  </responsible_party>
  <keyword>functional magnetic resonance imaging</keyword>
  <keyword>eating behavior</keyword>
  <keyword>sugar</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

